Valsartan Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-R-0011

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued a solicitation (SPE2D2-26-R-0011) for the supply of Valsartan Tablets. This procurement is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and carries the Product Service Code 6505, indicating a focus on drugs and biologicals. The primary objective of this solicitation is to secure a reliable source of Valsartan Tablets, a pharmaceutical product commonly used in the treatment of high blood pressure and heart conditions. The intended outcome is to ensure the consistent availability of this medication for military and federal healthcare needs, supporting the health and readiness of service members and other beneficiaries. Contractors responding to this opportunity should be capable of manufacturing and delivering Valsartan Tablets in accordance with federal standards and requirements. While the specific technical and quality requirements are not detailed in the notice, it is expected that all deliverables must comply with applicable pharmaceutical regulations and DLA Troop Support specifications. Interested parties are encouraged to review the solicitation documents available via the provided SAM.gov link for comprehensive requirements and submission instructions. The solicitation is open and active, with a posting date of June 23, 2026, and a response deadline of July 23, 2026. The procurement is managed by DLA Troop Support, a federal office within the Defense Logistics Agency, and is overseen by primary contact Ryan Guarnere ([email protected], 445-737-1729) and secondary contact Jason Wray ([email protected], 445-737-6304). Contractors seeking further information or clarification are encouraged to reach out to these contacts. No information regarding set-aside requirements, special considerations, or procurement type (such as small business set-aside or sole source) is provided in the notice. Contractors should consult the attached solicitation document for any additional details and requirements. This opportunity is suitable for manufacturers with proven capabilities in pharmaceutical production, particularly those experienced in supplying government and defense agencies. The scope and requirements are expected to remain consistent throughout the contract lifecycle, focusing on the reliable provision of Valsartan Tablets to meet federal healthcare needs. For full details and access to solicitation documents, contractors should visit the official SAM.gov opportunity page at: https://sam.gov/opp/d3eaf90d9667475d8b7634c5b95cbc89/view.